MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-04-2026
Sensus Healthcare DSO Ratio 2011-2026 | SRTS
Annual DSO Ratio Sensus Healthcare
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 171 | 133 | 209 | 121 | 107 | 144 | 188 | 182 | 87.9 | 76.4 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 209 | 76.4 | 142 |
Quarterly DSO Ratio Sensus Healthcare
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 146 | 191 | 206 | - | 182 | - | - | - | 188 | 221 | 401 | - | 89.7 | 78.8 | 100 | - | 71.4 | 72.7 | 116 | - | 213 | 291 | 483 | - | 219 | 171 | 228 | - | 189 | 198 | 139 | - | 94.3 | 91.1 | 84.4 | - | 85 | 79.2 | 77.7 | - | 89.7 | 39.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 483 | 39.5 | 161 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | USA |
 |
FONAR Corporation
FONR
|
237 | $ 18.58 | -0.11 % | $ 122 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.8 | $ 12.0 | -0.58 % | $ 1.62 B | USA |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Globus Medical
GMED
|
76.8 | $ 90.43 | 2.07 % | $ 12.2 B | USA |
 |
ClearPoint Neuro
CLPT
|
55.6 | $ 9.11 | -2.88 % | $ 258 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
57.3 | $ 36.38 | -0.98 % | $ 5.42 K | USA |
 |
Helius Medical Technologies
HSDT
|
53.3 | $ 1.8 | -5.53 % | $ 1.09 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
60.3 | $ 9.25 | -0.64 % | $ 712 M | USA |
 |
Inspire Medical Systems
INSP
|
42.6 | $ 54.48 | 0.63 % | $ 1.6 B | USA |
 |
IRIDEX Corporation
IRIX
|
47.5 | $ 1.03 | 3.35 % | $ 17.4 M | USA |
 |
Integer Holdings Corporation
ITGR
|
58.2 | $ 85.52 | -0.13 % | $ 2.97 B | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
LENSAR
LNSR
|
38.9 | $ 5.77 | -2.04 % | $ 69 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 15.82 | -0.75 % | $ 371 M | USA |
 |
Medtronic PLC
MDT
|
68.8 | $ 86.33 | 0.06 % | $ 111 B | USA |
 |
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.42 | -1.16 % | $ 128 M |  France |
 |
Myomo
MYO
|
35.3 | $ 0.67 | -4.85 % | $ 28 M | USA |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
86.7 | $ 168.21 | -2.13 % | $ 12.6 B | USA |
 |
Orthofix Medical
OFIX
|
60 | $ 11.81 | 0.34 % | $ 468 M |  Curacao |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
40.7 | $ 31.01 | -4.99 % | $ 1.43 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | USA |
 |
Insulet Corporation
PODD
|
40.7 | $ 204.23 | 0.36 % | $ 14.4 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
Sintx Technologies
SINT
|
67 | $ 2.76 | 9.09 % | $ 7.65 M | USA |
 |
Butterfly Network
BFLY
|
76.1 | $ 4.02 | -2.66 % | $ 851 M | USA |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
Stryker Corporation
SYK
|
204 | $ 331.18 | -0.34 % | $ 127 B | USA |
 |
Tactile Systems Technology
TCMD
|
49.2 | $ 24.16 | -1.67 % | $ 553 M | USA |
 |
Cytosorbents Corporation
CTSO
|
73.2 | $ 0.61 | 3.37 % | $ 38 M | USA |
 |
TELA Bio
TELA
|
46.5 | $ 0.7 | 11.11 % | $ 32.9 M | USA |
 |
TransMedics Group
TMDX
|
54.9 | $ 107.91 | 2.97 % | $ 3.67 B | USA |
 |
Tandem Diabetes Care
TNDM
|
176 | $ 18.66 | -2.66 % | $ 1.27 B | USA |
 |
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
48.5 | $ 9.68 | -0.21 % | $ 347 M | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
65.7 | $ 61.33 | -2.01 % | $ 90.8 B | USA |
 |
Alphatec Holdings
ATEC
|
43.1 | $ 11.09 | 1.05 % | $ 1.66 B | USA |